-
Something wrong with this record ?
Postremission cytopenia management in patients with acute myeloid leukemia treated with venetoclax and azacitidine in VIALE-A
KW. Pratz, CD. DiNardo, D. Selleslag, J. Li, K. Yamamoto, M. Konopleva, D. Stevens, H. Kantarjian, F. Traina, A. Venditti, J. Mayer, M. Montez, H. Jin, Y. Duan, D. Brackman, J. Zha, J. Potluri, M. Werner, BA. Jonas
Language English Country United States
Document type Letter
NLK
Free Medical Journals
from 1998 to 1 year ago
Wiley Free Content
from 1996 to 1 year ago
PubMed
36054316
DOI
10.1002/ajh.26692
Knihovny.cz E-resources
- MeSH
- Leukemia, Myeloid, Acute * drug therapy MeSH
- Azacitidine * therapeutic use MeSH
- Bridged Bicyclo Compounds, Heterocyclic therapeutic use MeSH
- Humans MeSH
- Antineoplastic Combined Chemotherapy Protocols adverse effects MeSH
- Sulfonamides therapeutic use MeSH
- Check Tag
- Humans MeSH
- Publication type
- Letter MeSH
AbbVie Inc North Chicago Illinois USA
Aichi Cancer Center Chikusa ku Nagoya Japan
Algemeen Ziekenhuis Sint Jan Brugge Oostende Belgium
Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas USA
Genentech Inc South San Francisco California USA
Hematology Department of Biomedicine and Prevention University Tor Vergata Rome Italy
Norton Cancer Institute Louisville Kentucky USA
Ruijin Hospital Shanghai China
University Hospital Brno and Masaryk University Brno Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22032864
- 003
- CZ-PrNML
- 005
- 20230131150651.0
- 007
- ta
- 008
- 230120s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/ajh.26692 $2 doi
- 035 __
- $a (PubMed)36054316
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Pratz, Keith W $u Department of Medicine, Hematology-Oncology Section, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA $1 https://orcid.org/0000000212848266
- 245 10
- $a Postremission cytopenia management in patients with acute myeloid leukemia treated with venetoclax and azacitidine in VIALE-A / $c KW. Pratz, CD. DiNardo, D. Selleslag, J. Li, K. Yamamoto, M. Konopleva, D. Stevens, H. Kantarjian, F. Traina, A. Venditti, J. Mayer, M. Montez, H. Jin, Y. Duan, D. Brackman, J. Zha, J. Potluri, M. Werner, BA. Jonas
- 650 _2
- $a protokoly protinádorové kombinované chemoterapie $x škodlivé účinky $7 D000971
- 650 12
- $a azacytidin $x terapeutické užití $7 D001374
- 650 _2
- $a bicyklické sloučeniny heterocyklické $x terapeutické užití $7 D019086
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a akutní myeloidní leukemie $x farmakoterapie $7 D015470
- 650 _2
- $a sulfonamidy $x terapeutické užití $7 D013449
- 655 _2
- $a dopisy $7 D016422
- 700 1_
- $a DiNardo, Courtney D $u Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA $1 https://orcid.org/0000000190030390
- 700 1_
- $a Selleslag, Dominik $u Algemeen Ziekenhuis Sint Jan, Brugge-Oostende, Belgium
- 700 1_
- $a Li, Junmin $u Ruijin Hospital, Shanghai, China
- 700 1_
- $a Yamamoto, Kazuhito $u Aichi Cancer Center, Chikusa-ku, Nagoya, Japan
- 700 1_
- $a Konopleva, Marina $u Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA $1 https://orcid.org/0000000293472212
- 700 1_
- $a Stevens, Don $u Norton Cancer Institute, Louisville, Kentucky, USA
- 700 1_
- $a Kantarjian, Hagop $u Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA $1 https://orcid.org/0000000219083307
- 700 1_
- $a Traina, Fabiola $u Department of Medical Imaging, Haematology, and Oncology, University of São Paulo at Ribeirão Preto Medical School, Sao Paulo, Brazil
- 700 1_
- $a Venditti, Adriano $u Hematology, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy $1 https://orcid.org/0000000202450553
- 700 1_
- $a Mayer, Jiri $u University Hospital Brno and Masaryk University, Brno, Czech Republic
- 700 1_
- $a Montez, Melissa $u Genentech, Inc, South San Francisco, California, USA
- 700 1_
- $a Jin, Huan $u Genentech, Inc, South San Francisco, California, USA
- 700 1_
- $a Duan, Yinghui $u AbbVie, Inc, North Chicago, Illinois, USA
- 700 1_
- $a Brackman, Deanna $u AbbVie, Inc, North Chicago, Illinois, USA
- 700 1_
- $a Zha, Jiuhong $u AbbVie, Inc, North Chicago, Illinois, USA
- 700 1_
- $a Potluri, Jalaja $u AbbVie, Inc, North Chicago, Illinois, USA
- 700 1_
- $a Werner, Michael $u AbbVie, Inc, North Chicago, Illinois, USA
- 700 1_
- $a Jonas, Brian A $u Department of Internal Medicine, Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento, California, USA $1 https://orcid.org/0000000249215809
- 773 0_
- $w MED00000251 $t American journal of hematology $x 1096-8652 $g Roč. 97, č. 11 (2022), s. E416-E419
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36054316 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230120 $b ABA008
- 991 __
- $a 20230131150647 $b ABA008
- 999 __
- $a ok $b bmc $g 1891546 $s 1184199
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 97 $c 11 $d E416-E419 $e 20220916 $i 1096-8652 $m American journal of hematology $n Am J Hematol $x MED00000251
- LZP __
- $a Pubmed-20230120